Navigation Links
Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2010 Results
Date:1/25/2010

GLENWOOD, Ill., Jan. 25 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR), will release financial results for the fiscal first quarter of 2010 pre-market on Tuesday, February 2, 2010.

The company will host a conference call for investors on Tuesday, February 2, 2010, at 2:00 p.m. Eastern Time. Investors may access the live call by dialing 877-941-8631 (within the United States and Canada), or 480-629-9820 (international callers), or by visiting the "Investors" page on the company's website at www.landauerinc.com.  Please log on to the website at least 15 minutes early to register, download and install any necessary audio software.

Investors may access a replay of the call by dialing 800-406-7325 (within the United States and Canada), or 303-590-3030 (international callers), passcode 4205610#, which will be available through Tuesday, March 2, 2010.  The replay will also be available on Landauer's website for 90 days following the call.

About Landauer

Landauer is the world's leading provider of technical and analytical services to determine occupational and environmental radiation exposure and is the leading domestic provider of outsourced medical physics services.   For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees.  Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings.  The Company provides its dosimetry services to approximately 1.6 million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia, Mexico and other countries.  In addition, through its Global Physics Solutions subsidiary, the Company provides therapeutic and diagnostic physics services and educational services to the medical physics community.

For the latest news releases and other corporate documents on Landauer Inc.,

visit www.landauerinc.com

SOURCE Landauer, Inc.

RELATED LINKS
http://www.landauerinc.com

'/>"/>

SOURCE Landauer, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results
2. Roche responds to announcement of IDEAL hepatitis C trial results
3. Statement from the American Diabetes Association Related to ACCORD Trial Announcement
4. MannKind Addresses Pfizers Announcement Regarding Exubera
5. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
6. Lung Cancer Alliance Hails Announcement of New Erbitux(R) Data
7. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
8. Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study
9. CDC Urges Pre-Teen Vaccination With New Public Service Announcements
10. Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio
11. Michigan Catholic Conference Welcomes Announcement of Non-Embryo Destructive Stem Cell Research Advancement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Feb. 17, 2017  BioDigital, Inc., creators of ... of their 3D body mapping technology with eClinicalWorks, ... new integration will be used to capture and ... of the human body. BioDigital pilots show using ... while also increasing the precision of clinical annotations ...
(Date:2/17/2017)... -- Noble Capital Markets announced today that it has initiated ... EPIX ). The report was issued by Noble,s Head ... ESSA Pharmaceuticals is a clinical stage biopharmaceutical company ... lead compound EPI-506, is a small molecule oral drug ... receptor, thereby has potential to overcome some of the ...
(Date:2/16/2017)... 16, 2017 Research and Markets has ... Medical Device Technologies" report to their offering. ... Traditional medical ... general instruments, non-drug coated implantables, large endoscopes, needle based drug ... over the last two to three decades for the treatment ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... ... exhibitor at Molecular Medicine Tri-Conference February 20 – 22 in San Francisco. As ... showcase its anatomic and molecular pathology workflow solution, as well as its new ...
(Date:2/17/2017)... ... 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from around the ... - 23 in Beaver Creek, CO. It was announced today by Cindy Lovelace, executive ... Beaver Creek, hosting over 60 faculty members and addressing unmet needs of the NET ...
(Date:2/17/2017)... ... February 17, 2017 , ... Dillon Ruxton ... families and business owners in the greater Fort Lauderdale metropolitan region, is embarking ... For more than 30 years, LifeNet 4 Families has provided a broad range ...
(Date:2/16/2017)... ... February 17, 2017 , ... For some cancer ... their final treatments. Physician researchers at The Marcus Institute of Integrative Health ... for efficacy in reducing symptoms of traumatic stress in cancer patients and ...
(Date:2/16/2017)... ... February 17, 2017 , ... ... planning services to families and entrepreneurs in the Birmingham area, is announcing an ... who needs assistance with her medically challenged son, Anius. , Anius is medically ...
Breaking Medicine News(10 mins):